Protein & Cell >

2015 , Vol. 06 >Issue 12: 924 - 928

DOI: https://doi.org/10.1007/s13238-015-0225-6

LETTER

Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach

  • Yuwei Bai 1,2 ,
  • Shinya Tashiro 3 ,
  • Satoru Nagatoishi 3 ,
  • Toru Suzuki 1,2 ,
  • Dongke Yan 1,2 ,
  • Ruihua Liu 1,2 ,
  • Kouhei Tsumoto , 3 ,
  • Mark Bartlam , 1,2
Expand
  • 1. State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China
  • 2. College of Life Sciences, Nankai University, Tianjin 300071, China
  • 3. Medical Proteomics Laboratory, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108–8639, Japan
  • 4. Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University, 1919-1 Onna-son, Kunigami, Okinawa 904-0412, Japan

Published date: 04 Jan 2016

Copyright

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fold

Cite this article

Yuwei Bai , Shinya Tashiro , Satoru Nagatoishi , Toru Suzuki , Dongke Yan , Ruihua Liu , Kouhei Tsumoto , Mark Bartlam . Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach[J]. Protein & Cell, 2015 , 06(12) : 924 -928 . DOI: 10.1007/s13238-015-0225-6

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Doidge R, Mittal S, Aslam A, Winkler GS (2012) The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex. PLoS One 7:e51331

2
Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z, Yamashita Y, Zheng D, Shyu AB (2007) Human TOB, an antiproliferative transcription factor, is a poly(A)-binding proteindependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27:7791–7801

DOI

3
Ezzeddine N, Chen CY, Shyu AB (2012) Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities. Mol Cell Biol 32:1089–1098

DOI

4
Giannetti AM, Koch BD, Browner MF (2008) Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. J Med Chem 51:574–580

DOI

5
Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 41:856–864

DOI

6
Horiuchi M, Takeuchi K, Noda N, Muroya N, Suzuki T, Nakamura T, Kawamura-Tsuzuku J, Takahasi K, Yamamoto T, Inagaki F (2009) Structural basis for the antiproliferative activity of the Tob-hCaf1 complex. J Biol Chem 284:13244–13255

DOI

7
Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K (2005) Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 220:237–242

DOI

8
Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, Tsuzuku KT, Yamamoto T (2003) Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202:71–79

DOI

9
Jia S, Meng A (2007) Tob genes in development and homeostasis. Dev Dyn 236:913–921

DOI

10
Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67–72

DOI

11
Mauxion F, Chen CY, Seraphin B, Shyu AB (2009) BTG/TOB factors impact deadenylases. Trends Biochem Sci 34:640–647

DOI

12
Pfaff SJ, Chimenti MS, Kelly MJ, Arkin MR (2015) Biophysical methods for identifying fragment-based inhibitors of proteinprotein interactions. Methods Mol Biol 1278:587–613

DOI

13
Suzuki T, Tsuzuku J, Hayashi A, Shiomi Y, Iwanari H, Mochizuki Y, Hamakubo T, Kodama T, Nishitani H, Masai H (2012) Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob. J Biol Chem 287:40256–40265

DOI

14
Winkler GS (2010) The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222:66–72

DOI

15
Yang X, Morita M, Wang H, Suzuki T, Yang W, Luo Y, Zhao C, Yu Y, Bartlam M, Yamamoto T (2008) Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1deadenylase activity. Nucleic Acids Res 36:6872–6881

DOI

Options
Outlines

/

〈 〉